Institute for Natural Medicine Launches Public Outreach Campaign
The Institute for Natural Medicine says it aims to “support the advancement of naturopathic medicine” by increasing public awareness through its new ambassador program.
Photo © iStockphoto.com/milosducati
The Institute for Natural Medicine (INM; Washington, DC), a non-profit organization dedicated to increasing access to care by licensed naturopathic doctors, announced last week that it has launched the INM Ambassador Program to increase public awareness around the value of naturopathic medicine. The program will involve INM clinician and student ambassadors who will participate in coordinated outreach campaigns directed at both healthcare consumers and other health professionals.
As the interest and availability of naturopathic medicine has increased, so too has confusion around what naturopathic medicine does and doesn’t offer, INM explains. To that end, INM’s mission includes a push for rigorous licensing standards of naturopathic practitioners in all 50 states, as well as “building bridges with other health care disciplines.”
“A variety of practitioners with a wide range of experience, training, certification, and general competence practice under the umbrella of natural medicine, and that has made it difficult and confusing for consumers to understand,” said Michelle Simon, PhD, ND, president of the INM, in the program announcement. “We are committed to educating the public about the benefits of naturopathic medicine and connecting patients to legitimate licensed NDs in their region.”
Read more:
More Than 50 Companies Already in CRN’s Supplement OWL Database
NPA Invites Experts to Advise New Supplement Safety and Compliance Initiative
2017 Ingredient Trends to Watch for Food, Drinks, and Dietary Supplements: Prebiotics
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
